What is SPDR S&P Biotech ETF?
About SPDR® S&P Biotech ETF The investment seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of the S&P Biotechnology Select Industry Index derived from the biotechnology segment of a U.S. total market composite index.
What companies are in SPDR S&P Biotech ETF?
SPDR S&P Biotech ETF
| Symbol | Holding | % Assets |
|---|---|---|
| VRTX | Vertex Pharmaceuticals Incorporated | 1.15% |
| KRTX | Karuna Therapeutics, Inc. | 1.13% |
| BMRN | BioMarin Pharmaceutical Inc. | 1.10% |
| EXEL | Exelixis, Inc. | 1.10% |
Which is better Xbi or IBB?
XBI is an equal-weight ETF, whereas IBB is cap weighted. That gives XBI a potential performance advantage when smaller biotech stocks are surging, but it also makes the ETF more volatile than its cap-weighted peer. XBI’s three-year annualized volatility is nearly 800 basis points higher than that of IBB.
What is the biotech ETF symbol?
IBB – iShares Biotechnology ETF
| Previous Close | 129.07 |
|---|---|
| Day’s Range | 130.28 – 132.96 |
| 52 Week Range | 118.60 – 177.37 |
| Volume | 2,719,884 |
| Avg. Volume | 2,799,273 |
Is IBB a good buy?
IBB has traded between $145.27 and $176.21 in this past 52-week period. The fund has a beta of 0.86 and standard deviation of 25.51% for the trailing three-year period, which makes IBB a high risk choice in this particular space. With about 270 holdings, it effectively diversifies company-specific risk.
What is the best genomic ETF?
Here are the seven best biotech ETFs to buy:
- iShares Biotechnology ETF (IBB)
- SPDR S&P Biotech ETF (XBI)
- ARK Genomic Revolution ETF (ARKG)
- First Trust NYSE Arca Biotechnology ETF (FBT)
- iShares Genomics Immunology and Healthcare ETF (IDNA)
- Invesco Dynamic BioTech & Genome ETF (PBE)
Is IBB ETF a good investment?
IShares Biotechnology ETF is an excellent option for investors seeking to outperform the Health Care ETFs segment of the market. There are other ETFs in the space which investors could consider as well.
What is the largest biotech ETF?
IBB
The leading biotech ETF by assets, IBB has nearly $10 billion under management and is one of the most established ways to get exposure to the high-growth corner of health care.
Should I buy IBB ETF?
IShares Biotechnology ETF holds a Zacks ETF Rank of 1 (Strong Buy), which is based on expected asset class return, expense ratio, and momentum, among other factors. Because of this, IBB is a great option for investors seeking exposure to the Health Care ETFs segment of the market.
What is the IBB ETF Why would someone invest in it?
The investment seeks to track the investment results of the ICE Biotechnology Index composed of U.S.-listed equities in the biotechnology sector.